Labcorp Holdings Inc. logo

Labcorp Holdings Inc. (N6B)

Market Open
27 Feb, 20:00
XBER XBER
212. 00
0
0%
19.51B Market Cap
- P/E Ratio
2.72% Div Yield
0 Volume
- Eps
212
Previous Close
Day Range
212 212
Year Range
182 248
Want to track N6B and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
LH earnings report is expected in 55 days (27 Apr 2026)

Summary

N6B trading today higher at €212, an increase of 0% from yesterday's close, completing a monthly increase of 0% or €0. Over the past 12 months, N6B stock gained 0%.
N6B pays dividends to its shareholders, with the most recent payment made on Dec 11, 2025. The next announced payment will be in In 1 weeks on Mar 12, 2026 for a total of €0.72.
The last earnings report, released on Feb 17, 2026, missed the consensus estimates by -3.95%. On average, the company has fell short of earnings expectations by -1.25%, based on the last three reports. The next scheduled earnings report is due on Apr 27, 2026.
Labcorp Holdings Inc. has completed 5 stock splits, with the recent split occurring on May 20, 2024.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NYSE (USD).

N6B Chart

Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term

Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 week ago
Here's Why Labcorp Holdings (LH) is a Strong Value Stock

Here's Why Labcorp Holdings (LH) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 week ago
Labcorp Q4 Earnings Beat, Revenues Miss, Stock Down in Pre-Market

Labcorp Q4 Earnings Beat, Revenues Miss, Stock Down in Pre-Market

LH beats Q4 EPS estimates with 18% growth, but a revenue miss and cautious investor reaction push shares lower in pre-market trading.

Zacks | 1 week ago

Labcorp Holdings Inc. (N6B) FAQ

What is the stock price today?

The current price is €212.00.

On which exchange is it traded?

Labcorp Holdings Inc. is listed on XBER.

What is its stock symbol?

The ticker symbol is N6B.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.72%.

What is its market cap?

As of today, the market cap is 19.51B.

When is the next earnings date?

The next earnings report will release on Apr 27, 2026.

Has Labcorp Holdings Inc. ever had a stock split?

Labcorp Holdings Inc. had 5 splits and the recent split was on May 20, 2024.

Labcorp Holdings Inc. Profile

Health Care Providers & Services Industry
Healthcare Sector
Adam H. Schechter CEO
XBER Exchange
US5049221055 ISIN
US Country
60,900 Employees
12 Mar 2026 Last Dividend
3 Jul 2023 Last Split
29 Mar 1990 IPO Date

Overview

Laboratory Corporation of America Holdings, widely known as Labcorp, is a pioneering life sciences company that plays a crucial role in the healthcare industry by providing essential information aiding in clear and confident decision-making for doctors, hospitals, pharmaceutical companies, researchers, and patients. With a deep commitment to improving health and improving lives, Labcorp operates through two primary segments: Labcorp Diagnostics, which focuses on a wide array of testing services, and Labcorp Drug Development, dedicated to supporting the pharmaceutical and biotech industries in bringing new drugs and therapies to market. The company's history dates back to 1994, and it has since established its headquarters in Burlington, North Carolina, positioning itself as a leader in medical diagnostics and drug development services. Through its extensive range of services and a global network, Labcorp facilitates better health outcomes for millions of people worldwide.

Products and Services

Labcorp distinguishes itself by offering an extensive portfolio of services that cater to various stakeholders in the healthcare and biomedical sectors. Below are some of the key products and services provided by the company:

  • Diagnostic Tests - Labcorp conducts a wide range of routine and specialized diagnostic tests, including but not limited to, blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, vitamin D levels, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, and alcohol and substance-abuse tests. These tests are crucial for early detection, monitoring, and treatment of diseases.
  • Specialty Testing Services - The company provides gene-based and esoteric testing services targeting specific diseases and conditions. This includes anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing, offering advanced diagnostic solutions for complex health questions.
  • Occupational Testing Services - Labcorp extends its services to employers and managed care organizations (MCOs), delivering occupational testing services, medical drug monitoring, chronic disease programs, and kidney stone prevention tests. These services are designed to enhance workplace safety, compliance with regulations, and overall employee health.
  • Health and Wellness Services - The company offers health and wellness services, including health fairs, on-site and at-home testing, vaccinations, and health screenings. These services aim to promote preventative care and healthier lifestyles among employees and communities.
  • Online and Mobile Applications - To facilitate easier access to test results and services, Labcorp offers online and mobile applications that enable patients to view their test results conveniently. It also provides online applications for MCOs and accountable care organizations to manage and streamline healthcare services effectively.
  • Drug Development - Labcorp Drug Development unit offers comprehensive end-to-end drug development, medical device, and companion diagnostic development solutions. From early-stage research to clinical development and commercial market access, Labcorp supports a range of requirements for pharmaceutical, biotechnology, medical device, and diagnostics companies.

Contact Information

Address: 358 South Main Street
Phone: 336 229 1127